Literature DB >> 4328795

Postnatal decline of maternally acquired viral antibodies of different specificities.

M J Cloonan, R A Hawkes, L H Stevens.   

Abstract

The rates of decline (half-lives) of maternally acquired antibodies of two different specificities in a group of infants were found to be highly variable, ranging from 18 to 192 days for parainfluenza type 3 antibody (54 infants) and from 15 to 251 days for influenza A2 antibody (nine infants). For antibodies of both specificities approximately 75% of the half-lives were between 15 and 60 days. With parainfluenza type 3 antibody, and possibly with influenza A2 antibody, the half-lives were inversely proportional to the initial antibody titre of the babies' sera. This relationship could be described by a rectangular hyperbola. Babies with high antibody titres at birth lost this antibody rapidly whereas in babies with low initial titres antibody declined over a longer period.The half-lives of parainfluenza type 3 antibody and influenza A2 antibody were compared with that of rubella antibody in the same group of infants (previously published). Maternally acquired viral antibodies of different specificities did not necessarily decline at similar rates in any given child. In nine infants, maternally acquired antibodies of two different specificities (rubella and parainfluenza type 3) declined at significantly different rates in the same child. It is suggested that although the half-life of antibody of a given specificity is related to its concentration in the serum, it is independent of the level of serum antibodies of other specificities.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4328795      PMCID: PMC2130902          DOI: 10.1017/s0022172400021689

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  6 in total

1.  A THEORETICAL MODEL OF GAMMA-GLOBULIN CATABOLISM.

Authors:  F W BRAMBELL; W A HEMMINGS; I G MORRIS
Journal:  Nature       Date:  1964-09-26       Impact factor: 49.962

2.  Concentration of gamma-globulin in the serum of infants during the first 3 months of life.

Authors:  V E TREVORROW
Journal:  Pediatrics       Date:  1959-11       Impact factor: 7.124

3.  The transmission of immunity from mother to young and the catabolism of immunoglobulins.

Authors:  F W Brambell
Journal:  Lancet       Date:  1966-11-19       Impact factor: 79.321

Review 4.  Metabolism of immunoglobulins.

Authors:  T A Waldmann; W Strober
Journal:  Prog Allergy       Date:  1969

5.  Postnatal decline of maternally acquired rubella antibodies.

Authors:  M J Cloonan; R A Hawkes; L H Stevens
Journal:  J Hyg (Lond)       Date:  1970-09

6.  Disquisitions of Original Antigenic Sin. I. Evidence in man.

Authors:  R G Webster
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

  6 in total
  5 in total

1.  A comparison of the evolution of transmitted IgG immunoglobulin and diphtheria antitoxin titers in the newborn.

Authors:  N Cabau; F M Levy; D Martins
Journal:  Med Microbiol Immunol       Date:  1976-12-01       Impact factor: 3.402

2.  Haemagglutination-inhibition antibodies against influenza A and influenza B in maternal and neonatal sera.

Authors:  N Masurel; J I de Bruijne; H A Beuningh; H J Schouten
Journal:  J Hyg (Lond)       Date:  1978-02

3.  Decline of passively acquired antibodies in young and adult rats.

Authors:  M J Cloonan; G M Shortland
Journal:  Immunology       Date:  1976-05       Impact factor: 7.397

4.  Cord blood IgG and the risk of severe Plasmodium falciparum malaria in the first year of life.

Authors:  Linda M Murungi; Klara Sondén; Dennis Odera; Loureen B Oduor; Fatuma Guleid; Irene N Nkumama; Mark Otiende; David T Kangoye; Greg Fegan; Anna Färnert; Kevin Marsh; Faith H A Osier
Journal:  Int J Parasitol       Date:  2016-11-24       Impact factor: 3.981

5.  Multi-centre observational study of transplacental transmission of influenza antibodies following vaccination with AS03(A)-adjuvanted H1N1 2009 vaccine.

Authors:  Richard Puleston; George Bugg; Katja Hoschler; Justin Konje; James Thornton; Iain Stephenson; Puja Myles; Joanne Enstone; Glenda Augustine; Yvette Davis; Maria Zambon; Karl Nicholson; Jonathan Nguyen-Van-Tam
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.